EFPIA - NEWSLETTER

EFPIA Newsletter 16 June 2016

Highlight of the week

150616 EFPIA Annual Report for 2015 16 June 2015

Welcome to EFPIA’s Annual Report for 2015. The report covers the major issues that have impacted the industry over the past year and offers further insight into potential developments in and around our sector in the year ahead. It is divided into easily accessible sections and is accompanied by informative facts and statistics concerning the industry.

News

14 June 2016 160614 European CSRs must go beyond the realms of cost containment and fiscal sustainability...

EFPIA welcomes the proposals for CSRs published by the European Commission as part of the...

16 June 2016 160616 EBE, the European Biopharmaceutical Trade Association, unveils its leadership 2016-2018...

Discover the EBE Board of Directors for the 2016-2018 term.

From our blog

10 June 2016 160610 Evolution – Not Revolution

EFPIA's Richard Bergström discusses their role in making medicines more accessible and healthcare...

15 June 2016 160615 Perfecting access through embedded sustainability, pooling resources and consolidating...

Anthony Gitau discusses how access to medicines in Kenya can be perfected through embedded...

14 June 2016 160614 From Mouthwash to Medicine: Unexpected Innovations (Guest blog)

Jon Pender tells us the story of how Pauline Williams found an antiseptic in one of GSK's...

16 June 2016 160616 Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited...

Greg Perry discusses how voluntary patient pooling could encourage rapid scale-up of medicines...

16 June 2016 160616 Transparency Is Key When Collaborating With Healthcare Professionals (Guest blog)

Andrew Hotchkiss discusses the importance of transparency when collaborating with healthcare...

16 June 2016 160616 Tackling TB through Partnership (Guest blog)

Evan Lee discusses how partnership can help tackle multidrug-resistant tuberculosis (MDR-TB)...

Video

Powering Growth in Europe

For every Euro of direct value added by the pharmaceutical industry, more than 1.5 additional Euros are generated for the whole European economy.

What we're reading

Would Brexit compromise the future of UK science 16 June 2016 (BBC)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶